Metabolic fatty liver syndromes: where do we stand in 2024?
2024
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) Study
2024
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
No publications available.
2021
Concordance between Fibroscan and aspartate aminotransferase-to-platelet ratio index (APRI) using different cut-off values in 603 Asian adults with chronic hepatitis C virus (HCV) with no or compensated cirrhosis in Thailand and Malaysia.
2021
Metabolic-dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiracial urban population in Malaysia.
2021
The spectrum of gastrointestinal and liver diseases has an ethnic predilection: observations from a specialist clinic in Malaysia
2021
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
